Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic skin condition characterized by painful lumps under the skin, often in areas where skin rubs together, such as the armpits and groin. It can lead to abscesses and scarring.
Hidradenitis Suppurativa: Secukinumab Treatment Study
We are investigating the long-term effects of secukinumab on people with moderate to severe hidradenitis suppurativa. This study will help us understand its safety and effectiveness compared to a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a woman who is pregnant or breastfeeding?
- Are you currently taking any medications that could interfere with the study, such as immunosuppressants or certain treatments for autoimmune diseases?
- Do you have any severe or uncontrolled health conditions, like severe heart disease or uncontrolled diabetes?
- Are you planning to receive any live vaccines during the study?
- Are you between 18 and 65 years old?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Ain457
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Ordensklinikum Linz GmbH
Dep. Dermatology
Linz, Austria
Medical University Of Vienna
University Clinic of Dermatology
Vienna, Austria
Universitair Ziekenhuis Gent
2514: Dermatology
Ledeberg, Belgium
Sponsor: Novartis Pharma AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.